{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:24Z","timestamp":1787261004461,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017656","name":"Gordon and Marilyn Macklin Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpeds.2026.115159","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:32:34Z","timestamp":1779838354000},"page":"115159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acute Intensification May Reduce Persistent Coronary Artery Damage from Kawasaki Disease in Infants Younger Than 6 Months"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-4770","authenticated-orcid":false,"given":"Kirsten B.","family":"Dummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey D.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-2699","authenticated-orcid":false,"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.115159_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2026.115159_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2019.01.092","article-title":"Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease","volume":"281","author":"Grande Gutierrez","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jpeds.2026.115159_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpeds.2020.02.033","article-title":"Management of myocardial infarction in children with giant coronary artery aneurysms after Kawasaki disease","volume":"221","author":"Burns","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115159_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/INF.0b013e318266bcf9","article-title":"Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease","volume":"31","author":"Dominguez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2026.115159_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpeds.2021.06.022","article-title":"Evaluation of a Kawasaki disease risk model for predicting coronary artery aneurysms in a Japanese population: an analysis of post RAISE","volume":"237","author":"Miyata","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115159_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","article-title":"High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease","volume":"185","author":"Salgado","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115159_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/archdischild-2018-314967","article-title":"Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease","volume":"104","author":"Cameron","year":"2019","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2026.115159_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S2352-4642(23)00166-9","article-title":"Subgroups of children with Kawasaki disease: a data-driven cluster analysis","volume":"7","author":"Wang","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpeds.2026.115159_bib9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fped.2020.00384","article-title":"Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network","volume":"8","author":"Moreno","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpeds.2026.115159_bib10","first-page":"e481","article-title":"Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association [published correction appears in Circulation. 2025 Feb 25;151(8):e677-e679. doi:10.1161\/CIR.0000000000001313]","volume":"150","author":"Jone","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2026.115159_bib11","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2026.115159_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/archdischild-2023-325639","article-title":"Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis","volume":"108","author":"Miyata","year":"2023","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2026.115159_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/archdischild-2020-319810","article-title":"Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis","volume":"106","author":"Friedman","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2026.115159_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trail","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2026.115159_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007191","article-title":"Risk factors of coronary artery abnormalities and resistance to intravenous immunoglobulin plus corticosteroid therapy in severe Kawasaki disease: an analysis of post RAISE","volume":"14","author":"Miyata","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jpeds.2026.115159_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jpids\/piae112","article-title":"Primary adjunctive corticosteroids in the acute management of high-risk Kawasaki disease in a North American cohort","volume":"13","author":"Wang","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2026.115159_bib17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s40262-018-0653-6","article-title":"nfliximab pharmacokinetics are influenced by intravenous immunoglobulin administration in patients with Kawasaki disease","volume":"57","author":"Vande Casteele","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2026.115159_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016440","article-title":"Medium-term complications associated with coronary artery aneurysms after Kawasaki disease: a study from the International Kawasaki disease Registry","volume":"9","author":"McCrindle","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jpeds.2026.115159_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003289","article-title":"Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population","volume":"5","author":"Friedman","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jpeds.2026.115159_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/1756-185X.12854","article-title":"Kawasaki disease in infants below 6 months: a clinical conundrum","volume":"19","author":"Singh","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jpeds.2026.115159_bib21","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1542\/peds.2009-0099","article-title":"Kawasaki disease at the extremes of the age spectrum","volume":"124","author":"Manlhiot","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.115159_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00246-021-02571-8","article-title":"Epidemiology and risk factors for giant coronary artery aneurysms identified after acute Kawasaki disease","volume":"42","author":"Masuda","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2026.115159_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/cdr\/9988778","article-title":"Risk factors and regression of coronary aneurysms in infants with Kawasaki disease","volume":"2025","author":"Liu","year":"2025","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jpeds.2026.115159_bib24","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2026.115159_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011319","article-title":"Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population","volume":"8","author":"Son","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jpeds.2026.115159_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115159_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S2352-4642(21)00270-4","article-title":"Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial","volume":"5","author":"Burns","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpeds.2026.115159_bib28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","article-title":"Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"383","author":"Tremoulet","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2026.115159_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3341","article-title":"Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis","volume":"143","author":"Dionne","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.115159_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1756-185X.13208","article-title":"Adjunctive therapies in Kawasaki disease","volume":"21","author":"Tremoulet","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jpeds.2026.115159_bib31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1017\/S1047951119000982","article-title":"An update on the epidemiology, length of stay, and cost of Kawasaki disease hospitalisation in the United States","volume":"29","author":"Ghimire","year":"2019","journal-title":"Cardiol Young"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:23:54Z","timestamp":1787257434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347626001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0022347626001873"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115159","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Intensification May Reduce Persistent Coronary Artery Damage from Kawasaki Disease in Infants Younger Than 6 Months","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115159"}}